INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Sun Pharmaceutical Industries Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524715	ISIN Demat INE044A01036	Book Value 98.33	NSE Symbol SUNPHARMA	Dividend Yield (%) 0.8	Market Cap (₹ Cr.) 404,899.77	P/E 128.53	EPS 13.13	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	20,275.17	20,812.14	15,585.98	14,116.05	12,531.93
Sale of Products	19,843.53	20,394.63	15,518.50	13,988.40	11,906.74
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	431.64	417.51	67.48	127.65	625.19
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	20,275.17	20,812.14	15,585.98	14,116.05	12,531.93
Other Income	553.48	329.29	1,196.88	192.07	1,510.92
Total Revenue	20,828.65	21,141.43	16,782.86	14,308.12	14,042.85
Changes in Inventories	180.32	-237.93	-183.18	-179.64	138.60
Cost of Material Consumed	4,429.38	5,165.63	4,584.97	4,082.91	3,201.71
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	994.41	1,126.46	1,248.60	1,204.21	1,227.41
Employee Benefits	2,373.95	2,156.95	2,000.78	1,805.98	1,702.77
Total Other Expenses	6,797.22	6,178.43	5,266.25	4,945.58	3,549.79
Manufacturing / Operating Expenses	1,645.72	1,532.53	1,240.71	1,006.66	1,025.00
Administrative and Selling Expenses	4,754.86	4,326.42	3,759.99	3,549.24	2,149.04
Other Expenses	396.64	319.48	265.55	389.68	375.75
Finance Costs	784.08	472.18	388.10	267.52	408.01
Depreciation and Amortization	1,600.62	1,600.87	1,349.95	1,236.43	561.56
Total Expenses	17,159.98	16,462.59	14,655.47	13,362.99	10,789.85
Profit Before Exceptional Items and Tax	3,668.67	4,678.84	2,127.39	945.13	3,253.00
Exceptional Items Before Tax	-219.02	-2,937.79	-1,820.53	-89.56	0.00
Profit Before Extraordinary Items and Tax	3,449.65	1,741.05	306.86	855.57	3,253.00
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	3,449.65	1,741.05	306.86	855.57	3,253.00
Taxation	591.47	50.33	406.85	13.17	41.86
Current Tax	546.10	752.77	-553.58	244.91	386.46
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	45.37	-702.44	519.83	-231.74	-344.60
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	440.60	0.00	0.00
Profit After Tax	2,858.18	1,690.72	-99.99	842.40	3,211.14
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	2,858.18	1,690.72	-99.99	842.40	3,211.14
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	2,858.18	1,690.72	-99.99	842.40	3,211.14
Earning Per Share - Basic	11.90	7.00	-0.40	3.50	13.38
Earning Per Share - Diluted	11.90	7.00	-0.40	3.50	13.38
Operation Profit before Depreciation	6,053.37	6,751.89	3,865.44	2,449.08	4,222.57
Operating Profit after Depreciation	4,452.75	5,151.02	2,515.49	1,212.65	3,661.01
Dividend Per Share	13.50	11.50	10.00	7.50	4.00
Dividend Percentage	1,350.00	1,150.00	1,000.00	750.00	400.00
Equity Dividend	3,138.10	2,759.23	2,398.85	1,799.50	959.73
Weighted Average Shares - Basic	239.93	239.93	239.93	239.93	239.93
Weighted Average Shares - Diluted	239.93	239.93	239.93	239.93	239.93